WHO ICTRP trial
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
CTRI/2012/06/002727 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2012/06/002727 |
|---|---|
| Public title | FST-100 in the Treatment of Acute Adenoviral Conjunctivitis |
| Scientific title | A Proof-of-Concept, Multi-center, Randomized, Double- Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 (0.1% Dexamethasone and 0.6% PVP-Iodine) Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis |
| Primary sponsor | Foresight Biotherapeutics |
| Secondary sponsors | Excel Life Sciences Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Brazil;United States of America;India |
| Conditions | Health Condition 1: null- Acute Adenoviral Conjunctivitis Health Condition 2: B301- Conjunctivitis due to adenovirus |
| Interventions | Intervention1: FST100: Dexamethasone and Povidione-Iodine Dose: 1 drop Frequency: 4 times a day for 5 days Route of Administration: Topical Intervention2: FST100 (Component #1): Povidione Iodine Alone Dose: 1 drop Frequency: 4 times a day… |
| Registration date | Jun 14, 2012 |
| Target size | 308 |
| Secondary IDs | FST100-AVC-004 Version 1.0 dated November 14, 2011;NCT01470664 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: